MEIP
MEI Pharma Inc
Price:  
2.70 
USD
Volume:  
10,439.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

MEIP WACC - Weighted Average Cost of Capital

The WACC of MEI Pharma Inc (MEIP) is 8.5%.

The Cost of Equity of MEI Pharma Inc (MEIP) is 13.20%.
The Cost of Debt of MEI Pharma Inc (MEIP) is 5.00%.

Range Selected
Cost of equity 10.70% - 15.70% 13.20%
Tax rate 26.20% - 27.00% 26.60%
Cost of debt 5.00% - 5.00% 5.00%
WACC 7.2% - 9.7% 8.5%
WACC

MEIP WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 1.49 1.94
Additional risk adjustments 0.0% 0.5%
Cost of equity 10.70% 15.70%
Tax rate 26.20% 27.00%
Debt/Equity ratio 1 1
Cost of debt 5.00% 5.00%
After-tax WACC 7.2% 9.7%
Selected WACC 8.5%